| ADARs, RNA editing and more in hematological malignancies PJ Teoh, MY Koh, WJ Chng Leukemia 35 (2), 346-359, 2021 | 21 | 2021 |
| Histone methyltransferase NSD2 activates PKCα to drive metabolic reprogramming and lenalidomide resistance in multiple myeloma PSY Chong, JY Chooi, JSL Lim, ACY Leow, SHM Toh, I Azaman, MY Koh, ... Cancer Research 83 (20), 3414-3427, 2023 | 5 | 2023 |
| Deciphering the regulatory landscape of murine splenic response to anemic stress at single-cell resolution C Yang, R Yokomori, LH Chua, SH Tan, MY Koh, H Totani, T Sanda, ... Blood Advances 8 (7), 1651-1666, 2024 | 1 | 2024 |
| Resistance to immunomodulatory drugs in multiple myeloma: the cereblon pathway and beyond PJ Teoh, MY Koh, C Mitsiades, S Gooding, WJ Chng Haematologica, 2020 | | 2020 |
